Clinical Trial Update: A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI [Phase 2]

View source ↗

Summary

A Phase 2 pilot randomized controlled trial evaluating intravenous N-acetylcysteine in patients with ST-segment elevation myocardial infarction (STEMI) has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stemi

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Alberta | Conditions: STEMI | Phase 2 | Status: COMPLETED